monocrotaline has been researched along with Cor Pulmonale in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, A; Campos, C; Corssac, G; Klein, AB; Lacerda, D; Llesuy, S; Tavares, AMV; Turck, P | 1 |
| Feng, Q; Qian, X; Zhao, H | 1 |
| Chen, W; Lei, C; Ouyang, S; Zeng, G | 1 |
| Araújo, AS; Belló-Klein, A; Colombo, R; Conzatti, A; Fernandes, TR; Siqueira, R; Tavares, AM | 1 |
| Araujo, AS; Belló-Klein, A; Caron-Lienert, R; Llesuy, S; Ludke, AR; Mosele, F; Partata, W; Ribeiro, MF; Singal, P | 1 |
| Cui, WY; Li, JS; Lng, CL; Wang, H | 1 |
| Butrous, G; Ermert, L; Ermert, M; Ghofrani, HA; Grimminger, F; Guenther, A; Kreisselmeier, KP; Rose, F; Schermuly, RT; Seeger, W; Walmrath, D; Weissmann, N; Yilmaz, H | 1 |
| Ermert, L; Ghofrani, HA; Grimminger, F; Kreisselmeier, KP; Pullamsetti, S; Samidurai, A; Schermuly, RT; Schudt, C; Seeger, W; Weissmann, N | 1 |
| Farahmand, F; Hill, MF; Singal, PK | 1 |
| Fujimori, A; Goto, K; Iemitsu, M; Miyauchi, T; Sakai, S; Sanagi, M; Shikama, H; Sudoh, K; Yamaguchi, I; Yuyama, H | 1 |
| Auzani, JA; Belló-Klein, A; Khaper, N; Picoral, M; Silva, LF; Souza-Rabbo, MP | 1 |
| Gauthier, D; Kay, JM; Keane, PM; Suyama, KL | 1 |
| Watanabe, S | 1 |
| Jones, AD; Lamé, MW; Pan, LC; Segall, HJ; Wilson, DW | 1 |
| Johnson, WD; Lalich, JL; Raczniak, TJ; Shumaker, RC | 1 |
| Lu, ZS | 1 |
| Ito, T; Kira, Y; Murata, M; Okabe, F; Sekine, I; Takahashi, M | 1 |
| Sun, BT | 2 |
| Langleben, D; Reid, LM | 1 |
20 other study(ies) available for monocrotaline and Cor Pulmonale
| Article | Year |
|---|---|
Effects of Copaiba Oil in Peripheral Markers of Oxidative Stress in a Model of Cor Pulmonale in Rats.
Topics: Animals; Hypertension, Pulmonary; Male; Monocrotaline; Oxidative Stress; Pulmonary Heart Disease; Rats; Rats, Wistar | 2021 |
Involvement of miR-200b-PKCα signalling in pulmonary hypertension in cor pulmonale model.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Monocrotaline; Protein Kinase C-alpha; Pulmonary Heart Disease; Signal Transduction | 2020 |
Aquaporin-2 expression in the kidney and urine is elevated in rats with monocrotaline-induced pulmonary heart disease.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Biomarkers; Disease Models, Animal; Humans; Hypertension, Pulmonary; Kidney; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Renal Elimination | 2020 |
Aerobic Exercise Promotes a Decrease in Right Ventricle Apoptotic Proteins in Experimental Cor Pulmonale.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Disease Models, Animal; Echocardiography; Hemodynamics; Hydrogen Peroxide; Hypertrophy, Right Ventricular; Male; Monocrotaline; Physical Conditioning, Animal; Pulmonary Artery; Pulmonary Heart Disease; Rats, Wistar; Vascular Resistance; Ventricular Function, Right; Ventricular Remodeling | 2015 |
Modulation of monocrotaline-induced cor pulmonale by grape juice.
Topics: Animals; Antioxidants; Beverages; Body Weight; Disease Models, Animal; Lipid Peroxidation; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Organ Size; Pulmonary Heart Disease; Rats; Rats, Wistar; Ventricular Pressure; Vitis | 2010 |
[Pathophysiological characteristics of rat pulmonary hypertension and cor pulmonale induced by monocrotaline].
Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide; Pulmonary Heart Disease; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2012 |
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats.
Topics: Administration, Oral; Animals; Biopsy, Needle; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Hemodynamics; Hypertension, Pulmonary; Immunohistochemistry; Male; Monocrotaline; Phosphodiesterase Inhibitors; Piperazines; Probability; Pulmonary Heart Disease; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Sildenafil Citrate; Sulfones; Survival Rate; Time Factors | 2004 |
Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Gelatinases; Hemodynamics; Hypertension, Pulmonary; Hypertrophy; Hypertrophy, Right Ventricular; Iloprost; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Muscle, Smooth, Vascular; Naphthyridines; Oxygen; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Gas Exchange; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Ventricular Remodeling | 2004 |
Antioxidant and oxidative stress changes in experimental cor pulmonale.
Topics: Animals; Antioxidants; Cardiomegaly; Catalase; Disease Models, Animal; Glutathione Peroxidase; Heart Ventricles; Lipid Peroxidation; Liver; Lung; Male; Monocrotaline; Organ Size; Oxidative Stress; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors; Ventricular Pressure | 2004 |
YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Coronary Vessels; Disease Models, Animal; Disease Progression; Endothelin A Receptor Antagonists; Heart Failure; Hemodynamics; Hypertension, Pulmonary; Ligation; Male; Monocrotaline; Myocardial Infarction; Pulmonary Heart Disease; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Sulfonamides | 2004 |
Effects of a chronic exercise training protocol on oxidative stress and right ventricular hypertrophy in monocrotaline-treated rats.
Topics: Animals; Catalase; Glutathione Transferase; Hypertrophy, Right Ventricular; Male; Monocrotaline; Oxidative Stress; Physical Conditioning, Animal; Pulmonary Heart Disease; Rats; Rats, Wistar; Superoxide Dismutase; Weight Gain | 2008 |
Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
Topics: Animals; Arterioles; Blood Pressure; Cardiomegaly; Female; Hypertension, Pulmonary; Lung; Monocrotaline; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Pulmonary Artery; Pulmonary Heart Disease; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1982 |
[Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
Topics: Animals; Hypertension, Pulmonary; Monocrotaline; Pulmonary Heart Disease; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1981 |
COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Topics: Animals; Body Weight; Cysteine; Glutathione; Lung; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley | 1993 |
Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
Topics: Animals; Cardiomegaly; Endothelium; Fibrin; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Pulmonary Embolism; Pulmonary Heart Disease; Pyrroles; Pyrrolizidine Alkaloids; Rats | 1977 |
[Changes in acetylcholine and acetylcholinesterase in blood during pulmonary hypertension].
Topics: Acetylcholine; Acetylcholinesterase; Animals; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Rats, Wistar; Tobacco Smoke Pollution | 1992 |
Pathological analysis of the right ventricular hypertrophy and ventricular interdependence in autopsied hearts with cor pulmonale and pulmonary hypertensive rat hearts.
Topics: Adult; Aged; Animals; Blood Pressure; Cardiomegaly; Female; Heart; Heart Septum; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Middle Aged; Monocrotaline; Myocardium; Organ Size; Pulmonary Heart Disease; Pulmonary Wedge Pressure; Pyrrolizidine Alkaloids; Rats | 1989 |
[Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
Topics: Animals; Arterioles; Hydralazine; Hypertension, Pulmonary; Lung; Macaca mulatta; Monocrotaline; Pulmonary Heart Disease; Pyrrolizidine Alkaloids | 1987 |
[Monocrotaline-induced cor pulmonale in the rhesus monkey: ultrastructural changes of lung and heart].
Topics: Animals; Lung; Macaca mulatta; Monocrotaline; Myocardium; Pulmonary Heart Disease; Pyrrolizidine Alkaloids | 1987 |
Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
Topics: Animals; Body Weight; Cardiomegaly; Heart Ventricles; Hypertension, Pulmonary; Male; Methylprednisolone; Monocrotaline; Pulmonary Heart Disease; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1985 |